|
| 37429434 | Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosa. | Clin Microbiol Infect | 2024 |
| 36095143 | Obesity Is Associated with Attenuated Tissue Immunity in COVID-19. | Am J Respir Crit Care Med | 2023 |
| 37965226 | Clinical significance of culture-negative, PCR-positive bronchoalveolar lavage results in severe pneumonia. | ERJ Open Res | 2023 |
| 37520413 | An Adjudication Protocol for Severe Pneumonia. | Open Forum Infect Dis | 2023 |
| 37546860 | Prolonged exposure to lung-derived cytokines is associated with inflammatory activation of microglia in patients with COVID-19. | bioRxiv | 2023 |
| 37831530 | Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' reply. | Aliment Pharmacol Ther | 2023 |
| 38042959 | Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulence. | Nat Commun | 2023 |
| 37975660 | Individual meropenem epithelial lining fluid and plasma PK/PD target attainment. | Antimicrob Agents Chemother | 2023 |
| 35696591 | Outcomes of Percutaneous Tracheostomy for Patients With SARS-CoV-2 Respiratory Failure. | J Bronchology Interv Pulmonol | 2023 |
| 37182534 | Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK). | Lancet Infect Dis | 2023 |
| 37147690 | Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial. | Crit Care | 2023 |
| 37012484 | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. | Intensive Care Med | 2023 |
| 37012080 | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. | Eur Respir J | 2023 |
| 37470277 | Early serum ammonia variation in critically ill patients with cirrhosis: A multicentre cohort study. | Aliment Pharmacol Ther | 2023 |
| 37104035 | Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19. | J Clin Invest | 2023 |
| 37195462 | Correction: ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. | Intensive Care Med | 2023 |
| 36856712 | Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report. | Ann Am Thorac Soc | 2023 |
| 36472425 | Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia. | Antimicrob Agents Chemother | 2023 |
| 36646082 | Clinical Features of COVID-19 and Differentiation from Other Causes of CAP. | Semin Respir Crit Care Med | 2023 |
| 36773112 | Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial. | Ann Intensive Care | 2023 |
| 36669500 | The impact of multidrug-resistant microorganisms on critically ill patients with cirrhosis in the intensive care unit: a cohort study. | Hepatol Commun | 2023 |
| 36628676 | Scores and Scores of Predicted Mortality Scores. | Chest | 2023 |
| 36171440 | Bronchoscopy for diagnosis of ventilator-associated pneumonia. | Intensive Care Med | 2023 |
| 34387183 | Decreasing incidence of <i>Acinetobacter baumannii</i> pneumonia and trends in antibiotic consumption: A single-center retrospective observational study. | Infect Control Hosp Epidemiol | 2022 |
| 35617985 | Clinical impact of bacterial syndromic testing in pneumonia. | Lancet Respir Med | 2022 |
| 36457059 | Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem. | Crit Care | 2022 |
| 35869779 | Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia. | J Antimicrob Chemother | 2022 |
| 36116810 | Novel and Rapid Diagnostics for Common Infections in the Critically Ill Patient. | Clin Chest Med | 2022 |
| 35085382 | Proactive vs Reactive Machine Learning in Health Care: Lessons From the COVID-19 Pandemic. | JAMA | 2022 |
| 35170002 | Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia. | Semin Respir Crit Care Med | 2022 |
| 35022730 | Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia. | J Antimicrob Chemother | 2022 |
| 34811567 | Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial. | Intensive Care Med | 2022 |
| 34694655 | Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patients. | Artif Organs | 2022 |
| 32785589 | A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study). | Clin Infect Dis | 2021 |
| 33720350 | A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia. | Clin Infect Dis | 2021 |
| 33517926 | Association between a rapid diagnostic test to detect methicillin-resistant <i>Staphylococcus Aureus</i> pneumonia and decreased vancomycin use in a medical intensive care unit over a 30-month period. | Infect Control Hosp Epidemiol | 2021 |
| 33905777 | Comprehensive evaluation of bronchoalveolar lavage from patients with severe COVID-19 and correlation with clinical outcomes. | Hum Pathol | 2021 |
| 33678269 | Empiric Carbapenems for Nosocomial Pneumonia: Is Hindsight Clearer in 2020? | Chest | 2021 |
| 33875439 | Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia. | Antimicrob Agents Chemother | 2021 |
| 33929301 | Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. | Am J Respir Crit Care Med | 2021 |
| 33833230 | Pneumonia. | Nat Rev Dis Primers | 2021 |
| 34899681 | miR-221-5p-Mediated Downregulation of JNK2 Aggravates Acute Lung Injury. | Front Immunol | 2021 |
| 34383901 | Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia. | J Antimicrob Chemother | 2021 |
| 34409924 | Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia. | Am J Respir Crit Care Med | 2021 |
| 34380538 | Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial. | Crit Care | 2021 |
| 34596927 | Antibiotic-resistant bacteria: COVID-19 hasn't made the challenge go away. | Respirology | 2021 |
| 34532730 | Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia. | J Antimicrob Chemother | 2021 |
| 33993256 | Reply to Chao and Lai. | Clin Infect Dis | 2021 |
| 34242148 | Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report. | Ann Am Thorac Soc | 2021 |
| 33982098 | Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults. | Clin Infect Dis | 2021 |